It has not been determined what role drugs may play in the treatment of cerebellar ataxia. In research done by Trouillas in Lyon, France, the pharmacology of cerebellar ataxia was examined by manipulating key components found at the nerve level within the cerebellum or the inferior Olive. This was done mostly through the modification of the GABA, dopamine, and serotonin receptors which did seem to show positive results in the primary stages of the experimentation. The clinical benefits presented in this study justifying the prescription of d-l-5-HTP or better with the l-5-HTP with benserazide to patients with certain cerebellar ataxias including that of<unk> . At the present as stated, this is the best indication for treatment of the cerebellar cortical atrophies. Even still, it is important to stress that the response to this treatment may be slow and irregular. Neuroplastic rehabilitation Previously, neuroplasticity used as a rehabilitation method was considered as a potential treatment for<unk> . However these studies were not further developed since the 1980s. With current techniques and research from the neuroscience community, this is still a viable option not to eliminate cerebellar ataxia, but to slow its progress of development.
Dyschronometria
Hypospermia
Oligospermia
Spermatorrhea
Delayed ejaculation
Premature ejaculation
Dyspareunia
Hematospermia